1. Therapy-Related Myelodysplasia: Somatic Mutations and Allogeneic Hematopoietic Cell Transplantation Outcomes. (April 2017) Authors: Nakamura, R.; Pham, A.; Gendzekhadze, K.; Min, L.; Pullarkat, V.; Al Malki, M.; O Donnell, M.; Cao, T.; Stein, A.; Khaled, S.; Ali, H.; Senitzer, D.; Michelle Afkhami, M.A.; Aoun, P.; Murata-Collins, J.; Forman, S.; Palmer, J.; Marcucci, G.; Pillai, R.; Aldoss, I. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PET‐ADAPTED NIVOLUMAB +/‐ ICE AS INITIAL SALVAGE THERAPY IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA. (12th June 2019) Authors: Herrera, A.F.; Chen, R.; Palmer, J.; Tsai, N.; McBride, K.; Song, J.; Mei, M.; Zain, J.; Nikolaenko, L.; Popplewell, L.; Nademanee, A.; Rosen, S.; Kwak, L.; Lee, H.; Forman, S. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. MDS AS A CAUSE FOR PROLONGED HEMATOLOGIC TOXICITY AFTER TREATMENT WITH CD19 TARGETED CAR‐T CELL THERAPY IN PATIENTS WITH RELAPSED REFRACTORY LYMPHOMA. (12th June 2019) Authors: Shouse, G.P.; Xue, T.; Herrera, A.; Siddiqi, T.; Zain, J.; Popplewell, L.; Forman, S.; Budde, E. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 507 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The oral Janus kinase/spleen tyrosine kinase inhibitor ASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate‐to‐severe atopic dermatitis: results from a randomized double‐blind placebo‐controlled study. (6th May 2019) Authors: Bissonnette, R.; Maari, C.; Forman, S.; Bhatia, N.; Lee, M.; Fowler, J.; Tyring, S.; Pariser, D.; Sofen, H.; Dhawan, S.; Zook, M.; Zammit, D.J.; Usansky, H.; Denis, L.; Rao, N.; Song, T.; Pavel, A.B.; Guttman‐Yassky, E. Journal: British journal of dermatology Issue: Volume 181:Number 4(2019) Page Start: 733 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P1296: SUPPRESSING SYNTHESIS OF THE LONG ISOFORM OF THE PROLACTIN RECEPTOR IS A TARGETED STRATEGY TO TREAT AUTOIMMUNE B-LYMPHOPROLIFERATIVE DISEASES AND B CELL MALIGNANCIES. (23rd June 2022) Authors: Taghi Khani, A.; Kumar, A.; Radecki, K.; Lee, S. J.; Sanchez Ortiz, A.; Lorenson, M.; Wu, X.; Koff, J.; Forman, S.; Gu, Z.; Walker, A.; Swaminathan, S. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PO-1171 Ten-year follow-up of tandem autologous transplantation with total marrow irradiation for myeloma. (May 2022) Authors: Ladbury, C.; Rincon, A.; Song, J.; Armenian, S.; Liu, A.; Spielberger, R.; Popplewell, L.; Sahebi, F.; Parker, P.; Forman, S.; Snyder, D.; Dagis, A.; Frankel, P.; Yang, D.; Wong, J.; Somlo, G. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S992 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. ASN002 demonstrates efficacy and improves inflammation in AD. (1st October 2019) Authors: Bissonnette, R.; Maari, C.; Forman, S.; Bhatia, N.; Lee, M.; Fowler, J.; Tyring, S.; Pariser, D.; Sofen, H.; Dhawan, S.; Zook, M.; Zammit, D.J.; Usansky, H.; Denis, L.; Rao, N.; Song, T.; Pavel, A.B.; Guttman‐Yassky, E. Journal: British journal of dermatology Issue: Volume 181:Number 4(2019) Page Start: e102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The oral Janus kinase/spleen tyrosine kinase inhibitor ASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate‐to‐severe atopic dermatitis: results from a randomized double‐blind placebo‐controlled study. (1st October 2019) Authors: Bissonnette, R.; Maari, C.; Forman, S.; Bhatia, N.; Lee, M.; Fowler, J.; Tyring, S.; Pariser, D.; Sofen, H.; Dhawan, S.; Zook, M.; Zammit, D.J.; Usansky, H.; Denis, L.; Rao, N.; Song, T.; Pavel, A.B.; Guttman‐Yassky, E. Journal: British journal of dermatology Issue: Volume 181:Number 4(2019) Page Start: 733 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. ASN002 证明有疗效并可改善AD 炎症. (1st October 2019) Authors: Bissonnette, R.; Maari, C.; Forman, S.; Bhatia, N.; Lee, M.; Fowler, J.; Tyring, S.; Pariser, D.; Sofen, H.; Dhawan, S.; Zook, M.; Zammit, D.J.; Usansky, H.; Denis, L.; Rao, N.; Song, T.; Pavel, A.B.; Guttman‐Yassky, E. Journal: British journal of dermatology Issue: Volume 181:Number 4(2019) Page Start: e113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗